Cancer-associated fibroblasts: Recent developments and emerging challenges

Seminars in Cancer Biology

Volumn 25, Issue , 2014, Pages 1-2

  Östman, Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

ANGIOGENESIS; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; EDITORIAL; FIBROBLAST; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HUMAN; IMMUNOSURVEILLANCE; MESENCHYME CELL; METASTASIS; NEOPLASM; PARACRINE SIGNALING; PHENOTYPE; RNA SEQUENCE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; METABOLISM; PATHOLOGY;

FIBROBLASTS; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84897517441     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.02.004     Document Type: Editorial

References (12)

1. Cheung R.K., Utz P.J. Screening: CyTOF-the next generation of cell detection. Nat Rev Rheumatol 2011, 7(9):502-503.
2. Shapiro E., Biezuner T., Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet 2013, 14(9):618-630.
3. Ke R., Mignardi M., Pacureanu A., Svedlund J., Botling J., Wahlby C., et al. In situ sequencing for RNA analysis in preserved tissue and cells. Nat Methods 2013, 10(9):857-860.
4. Driskell R.R., Lichtenberger B.M., Hoste E., Kretzschmar K., Simons B.D., Charalambous M., et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature 2013, 504(7479):277-281.
5. LeBleu V.S., Taduri G., O'Connell J., Teng Y., Cooke V.G., Woda C., et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013, 19(8):1047-1053.
6. Rajaram M., Li J., Egeblad M., Powers R.S. System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity. PLoS Genet 2013, 9(9):e1003789.
7. Roccaro A.M., Sacco A., Maiso P., Azab A.K., Tai Y.T., Reagan M., et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 2013, 123(4):1542-1555.
8. Luga V., Zhang L., Viloria-Petit A.M., Ogunjimi A.A., Inanlou M.R., Chiu E., et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012, 151(7):1542-1556.
9. Zhang X.H., Jin X., Malladi S., Zou Y., Wen Y.H., Brogi E., et al. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 2013, 154(5):1060-1073.
10. Wilson T.R., Fridlyand J., Yan Y., Penuel E., Burton L., Chan E., et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012, 487(7408):505-509.
11. Ostman A. The tumor microenvironment controls drug sensitivity. Nat Med 2012, 18(9):1332-1334.
12. Straussman R., Morikawa T., Shee K., Barzily-Rokni M., Qian Z.R., Du J., et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012, 487(7408):500-504.